Business
Press Release Jan 12 2026
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 12, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for BosutinibTablets, 400 mg".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 12, 2026, titled \"Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for BosutinibTablets, 400 mg\". View Attachment","length":383,"tagName":"div"}]